{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:54:51Z","timestamp":1787169291633,"version":"build-2736575974"},"reference-count":49,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sensors"],"abstract":"<jats:p>Parkinson\u2019s Disease is a progressive neurodegenerative disorder marked by motor fluctuations in later disease stages that complicate treatment with levodopa. Traditional approaches to dosing often fail to capture the complex and dynamic nature of these fluctuations. In this study, we present the PD9\u2122 algorithm, a novel approach to continuous motor state monitoring using data from a wrist-worn inertial measurement unit sensor. The algorithm provides minute-by-minute assessments of motor state severity on a unified scale quantifying bradykinesia, dyskinesia, and ON states. Data collected from 67 patients over 55,482 min were analyzed to assess levodopa response cycles. Across 218 identified levodopa cycles, the algorithm revealed reproducible patterns of symptom development based on the motor state at the time of levodopa administration. In particular, levodopa doses administered during non-ideal motor states (e.g., during dyskinesia) highlighted the limitations of fixed, empirically determined dosing regimens and underscore the need for individualized therapy, based on motor state. These findings demonstrate how AI-enabled continuous monitoring could help realize a more personalized treatment of Parkinson\u2019s disease and improve patient outcomes.<\/jats:p>","DOI":"10.3390\/s25237273","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:35:17Z","timestamp":1764956117000},"page":"7273","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["AI-Driven Analysis of Wrist-Worn Sensor Data for Monitoring Individual Treatment Response and Optimizing Levodopa Dosing in Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2276-3561","authenticated-orcid":false,"given":"Mathias","family":"Sander","sequence":"first","affiliation":[{"name":"Orbit Health GmbH, 81667 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7132-8491","authenticated-orcid":false,"given":"Moritz R.","family":"Messner","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital, Ludwig-Maximilians-University (LMU), 80539 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina K.","family":"Knapp","sequence":"additional","affiliation":[{"name":"Orbit Health GmbH, 81667 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz M. J.","family":"Pfister","sequence":"additional","affiliation":[{"name":"Orbit Health GmbH, 81667 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban M.","family":"Fietzek","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital, Ludwig-Maximilians-University (LMU), 80539 Munich, Germany"},{"name":"Department of Neurology and Clinical Neurophysiology, Sch\u00f6n Klinik M\u00fcnchen Schwabing, 80804 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected Number of People with Parkinson Disease in the Most Populous Nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"ref_2","unstructured":"Maserejian, N., Vinikoor-Imler, L., and Dilley, A. (2020, January 12\u201316). Estimation of the 2020 Global Population of Parkinson\u2019s Disease (PD). Proceedings of the MDS Virtual Congress 2020, Virtual."},{"key":"ref_3","first-page":"S3","article-title":"The Emerging Evidence of the Parkinson Pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for Prevalence of Parkinson\u2019s Disease and Its Driving Factors in 195 Countries and Territories to 2050: Modelling Study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"ref_5","unstructured":"Stoker, T.B., and Greenland, J.C. (2018). Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects, Exon Publications."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and Treatment of Parkinson Disease: A Review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson Disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The Epidemiology of Parkinson\u2019s Disease","volume":"403","author":"Darweesh","year":"2024","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson\u2019s Disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s Disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Church, F.C. (2021). Treatment Options for Motor and Non-Motor Symptoms of Parkinson\u2019s Disease. Biomolecules, 11.","DOI":"10.3390\/biom11040612"},{"key":"ref_12","first-page":"275","article-title":"Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa","volume":"7","author":"Othman","year":"2017","journal-title":"J. Park. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1208\/s12248-012-9439-1","article-title":"Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-Hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson\u2019s Disease Patients","volume":"15","author":"Nyholm","year":"2013","journal-title":"AAPS J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.0000000000002509","article-title":"Levodopa Therapy for Parkinson Disease: A Look Backward and Forward","volume":"86","author":"LeWitt","year":"2016","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(76)91416-1","article-title":"\u201cOn-off\u201d effects in patients with Parkinson\u2019s disease on chronic levodopa therapy","volume":"307","author":"Marsden","year":"1976","journal-title":"Lancet"},{"key":"ref_16","first-page":"11","article-title":"Motor Complications Associated with Chronic Levodopa Therapy in Parkinson\u2019s Disease","volume":"39","author":"Obeso","year":"1989","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Watts, J., Khojandi, A., Vasudevan, R., Nahab, F.B., and Ramdhani, R.A. (2021). Improving Medication Regimen Recommendation for Parkinson\u2019s Disease Using Sensor Technology. Sensors, 21.","DOI":"10.3390\/s21103553"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s40120-023-00486-5","article-title":"Clinical Use of On-Demand Therapies for Patients with Parkinson\u2019s Disease and OFF Periods","volume":"12","author":"Pahwa","year":"2023","journal-title":"Neurol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological Treatment of Parkinson Disease: A Review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Di Biase, L., Pecoraro, P.M., Carbone, S.P., Caminiti, M.L., and Di Lazzaro, V. (2023). Levodopa-Induced Dyskinesias in Parkinson\u2019s Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions. J. Clin. Med., 12.","DOI":"10.3390\/jcm12134427"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2174\/1570159X19666211116142806","article-title":"How to Optimize the Effectiveness and Safety of Parkinson\u2019s Disease Therapy?\u2014A Systematic Review of Drugs Interactions with Food and Dietary Supplements","volume":"20","author":"Agnieszka","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s Disease: Etiopathogenesis and Treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Emamzadeh, F.N., and Surguchov, A. (2018). Parkinson\u2019s Disease: Biomarkers, Treatment, and Risk Factors. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00612"},{"key":"ref_24","first-page":"100161","article-title":"Should \u201con-Demand\u201d Treatments for Parkinson\u2019s Disease OFF Episodes Be Used Earlier?","volume":"7","author":"Isaacson","year":"2022","journal-title":"Clin. Park. Relat. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s42466-024-00325-4","article-title":"Diagnosis and Treatment of Parkinson\u00b4s Disease (Guideline of the German Society for Neurology)","volume":"6","author":"Becktepe","year":"2024","journal-title":"Neurol. Res. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1007\/s00415-024-12546-3","article-title":"Guideline \u201cParkinson\u2019s Disease\u201d of the German Society of Neurology (Deutsche Gesellschaft F\u00fcr Neurologie): Concepts of Care","volume":"271","author":"Buhmann","year":"2024","journal-title":"J. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00415-020-10350-3","article-title":"Wearables in the Home-Based Assessment of Abnormal Movements in Parkinson\u2019s Disease: A Systematic Review of the Literature","volume":"269","author":"Ancona","year":"2022","journal-title":"J. Neurol."},{"key":"ref_28","first-page":"S35","article-title":"Body-Worn Sensors for Remote Monitoring of Parkinson\u2019s Disease Motor Symptoms: Vision, State of the Art, and Challenges Ahead","volume":"11","author":"Kirk","year":"2021","journal-title":"J. Park. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/mds.26642","article-title":"Technology in Parkinson\u2019s Disease: Challenges and Opportunities: Technology in PD","volume":"31","author":"Espay","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Giannakopoulou, K.-M., Roussaki, I., and Demestichas, K. (2022). Internet of Things Technologies and Machine Learning Methods for Parkinson\u2019s Disease Diagnosis, Monitoring and Management: A Systematic Review. Sensors, 22.","DOI":"10.3390\/s22051799"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-bioeng-062117-121036","article-title":"New Sensor and Wearable Technologies to Aid in the Diagnosis and Treatment Monitoring of Parkinson\u2019s Disease","volume":"21","author":"Monje","year":"2019","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_32","first-page":"57","article-title":"Wearable Sensor-Based Objective Assessment of Motor Symptoms in Parkinson\u2019s Disease","volume":"123","author":"Ossig","year":"2016","journal-title":"J. Neural Transm. Vienna Austria 1996"},{"key":"ref_33","unstructured":"National Institue for Health and Care Excellence (NICE) (2023). NICE Guideline: Devices for Remote Monitoring of Parkinson\u2019s Disease, NICE."},{"key":"ref_34","first-page":"1827","article-title":"Introducing the Parkinson\u2019s KinetiGraph into Routine Parkinson\u2019s Disease Care: A 3-Year Single Centre Experience","volume":"10","author":"Dominey","year":"2020","journal-title":"J. Park. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Pfister, F.M.J., Um, T.T., Pichler, D.C., Goschenhofer, J., Abedinpour, K., Lang, M., Endo, S., Ceballos-Baumann, A.O., Hirche, S., and Bischl, B. (2020). High-Resolution Motor State Detection in Parkinson\u2019s Disease Using Convolutional Neural Networks. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-61789-3"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/978-3-030-46133-1_24","article-title":"Wearable-Based Parkinson\u2019s Disease Severity Monitoring Using Deep Learning","volume":"Volume 11908","author":"Brefeld","year":"2020","journal-title":"Machine Learning and Knowledge Discovery in Databases"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored Revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005053-198506000-00005","article-title":"Assessment of Tardive Dyskinesia Using the Abnormal Involuntary Movement Scale","volume":"173","author":"Lane","year":"1985","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_39","first-page":"1","article-title":"Closing the Loop mit NeptuneTM\u2014Erste Erfahrungen mit der KI-Sensorl\u00f6sung zur Erfassung des motorischen Zustandes bei Menschen bit Parkinson","volume":"4","author":"Fietzek","year":"2024","journal-title":"Neuro Aktuell"},{"key":"ref_40","first-page":"89","article-title":"Levodopa Fractionation in Parkinson\u2019s Disease","volume":"4","author":"Nyholm","year":"2014","journal-title":"J. Park. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s40265-019-01098-w","article-title":"Contemporary Options for the Management of Motor Complications in Parkinson\u2019s Disease: Updated Clinical Review","volume":"79","author":"Cabreira","year":"2019","journal-title":"Drugs"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41531-023-00585-y","article-title":"Overview on Wearable Sensors for the Management of Parkinson\u2019s Disease","volume":"9","author":"Moreau","year":"2023","journal-title":"Npj Park. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"FitzGerald, J.J., Lu, Z., Jareonsettasin, P., and Antoniades, C.A. (2018). Quantifying Motor Impairment in Movement Disorders. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00202"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Sundgren, M., Andr\u00e9asson, M., Svenningsson, P., Noori, R.-M., and Johansson, A. (2021). Does Information from the Parkinson KinetiGraphTM (PKG) Influence the Neurologist\u2019s Treatment Decisions?-An Observational Study in Routine Clinical Care of People with Parkinson\u2019s Disease. J. Pers. Med., 11.","DOI":"10.3390\/jpm11060519"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Molinero, A., Sam\u00e0, A., P\u00e9rez-L\u00f3pez, C., Rodr\u00edguez-Mart\u00edn, D., Alcaine, S., Mestre, B., Quispe, P., Giuliani, B., Vainstein, G., and Browne, P. (2017). Analysis of Correlation between an Accelerometer-Based Algorithm for Detecting Parkinsonian Gait and UPDRS Subscales. Front. Neurol., 8.","DOI":"10.3389\/fneur.2017.00431"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00415-019-09183-6","article-title":"Sensor-Based Algorithmic Dosing Suggestions for Oral Administration of Levodopa\/Carbidopa Microtablets for Parkinson\u2019s Disease: A First Experience","volume":"266","author":"Thomas","year":"2019","journal-title":"J. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.parkreldis.2015.01.018","article-title":"Motion Sensor Strategies for Automated Optimization of Deep Brain Stimulation in Parkinson\u2019s Disease","volume":"21","author":"Pulliam","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Kim, Y., Suescun, J., Schiess, M.C., and Jiang, X. (2021). Computational Medication Regimen for Parkinson\u2019s Disease Using Reinforcement Learning. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-88619-4"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1109\/JBHI.2024.3423708","article-title":"Reinforcement Learning-Based Adaptive Classification for Medication State Monitoring in Parkinson\u2019s Disease","volume":"28","author":"Shuqair","year":"2024","journal-title":"IEEE J. Biomed. Health Inform."}],"container-title":["Sensors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8220\/25\/23\/7273\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:37:53Z","timestamp":1764956273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8220\/25\/23\/7273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":49,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["s25237273"],"URL":"https:\/\/doi.org\/10.3390\/s25237273","relation":{},"ISSN":["1424-8220"],"issn-type":[{"value":"1424-8220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}